See the DrugPatentWatch profile for Buspar
Buspar is the brand name for buspirone hydrochloride [1]. The active ingredient in Buspar is buspirone hydrochloride [1]. Buspirone hydrochloride is a medication used to treat anxiety disorders [2].
What is buspirone hydrochloride?
Buspirone hydrochloride is an anxiolytic medication, meaning it helps relieve anxiety [2]. Unlike benzodiazepines, which can cause sedation and have a risk of dependence, buspirone hydrochloride works differently and is not associated with these effects [3]. It belongs to a class of drugs known as azapirones [3].
How does buspirone hydrochloride work?
The exact mechanism of action for buspirone hydrochloride is not fully understood [3]. However, it is believed to primarily interact with serotonin receptors in the brain, specifically the 5-HT1A receptors [3]. It may also have some effect on dopamine receptors [3]. This interaction helps to regulate mood and reduce feelings of anxiety [3].
Buspar and its patents
Information regarding Buspar's specific patent status can be found through resources like DrugPatentWatch.com [4]. Patents are crucial for pharmaceutical companies as they grant exclusive rights to market a drug for a certain period, encouraging investment in research and development [4]. Once patents expire, generic versions of the medication can become available, often leading to lower prices [4].
What other ingredients are in Buspar?
In addition to the active ingredient buspirone hydrochloride, Buspar tablets contain inactive ingredients, also known as excipients [1]. These can vary slightly depending on the manufacturer and specific formulation but typically include:
* Lactose monohydrate [1]
* Microcrystalline cellulose [1]
* Sodium starch glycolate [1]
* Magnesium stearate [1]
* Silicon dioxide [1]
These inactive ingredients help to form the tablet, ensure stability, and facilitate proper absorption of the active drug in the body [1].
Sources
1. https://www.drugs.com/drug-dosage/buspar/
2. https://www.ncbi.nlm.nih.gov/books/NBK470427/
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916960/
4. https://drugpatentwatch.com/